HilleVax

HilleVax is a Massachusetts-based biopharmaceutical company that develops and commercializes novel vaccines for the treatment of acute gastroenteritis disorders.

Business Model:

Revenue: $0

Employees: 11-50

Detailed HilleVax Information

Geographic Data

HilleVax headquarters map

Address: 75 State Street

City: Boston

State: MA

Zip: 02109

Country: US

Financial Info

Stage:

series unknown

Raised Last:

$135M

Raised Total:

$135M

Metrics

1,797,378Website Global Rank

12,552Website Monthly Traffic

Twitter Followers

Description

HilleVax is a Massachusetts-based biopharmaceutical company that develops and commercializes novel vaccines for the treatment of acute gastroenteritis disorders.

Contact Phone:
+18883404544

Contact Email:

HilleVax went public on 4/29/2022 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
4/29/2022

IPO Valuation:
$538M

Ticker Symbol:
HLVX

IPO Price:
$17/share

Amount Raised:
$230M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research